Healthcare -
Biotechnology - NASDAQ - US
$ 54.0
-1.66 %
$ 3.37 B
Market Cap
-12.44
P/E
RYTM - STOCK-BASED COMPENSATION
Stock-based Compensation RYTM - Rhythm Pharmaceuticals, Inc.
32.6 M
LAST VALUE
25.09%
2 YEAR CAGR
38.49%
5 YEAR CAGR
74.13%
10 YEAR CAGR